ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

ClinicalTrials.gov ID: NCT05719441

Public ClinicalTrials.gov record NCT05719441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Study identification

NCT ID
NCT05719441
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
48 participants

Conditions and interventions

Interventions

  • ART Drug
  • PGT121.414.LS Biological
  • Placebo Other
  • VRC07-523LS Biological

Drug · Biological · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2024
Primary completion
Apr 5, 2028
Completion
Sep 5, 2028
Last update posted
Apr 20, 2026

2024 – 2028

United States locations

U.S. sites
32
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
31788, Alabama CRS Birmingham Alabama 35222 Not yet recruiting
1201, University of Southern California CRS Los Angeles California 90033-1079 Not yet recruiting
601, University of California, Los Angeles CARE Center CRS Los Angeles California 90035 Not yet recruiting
701, UCSD Antiviral Research Center CRS San Diego California 92103 Not yet recruiting
801, University of California, San Francisco HIV/AIDS CRS San Francisco California 94110 Not yet recruiting
603, Harbor University of California Los Angeles Center CRS Torrance California 90502 Not yet recruiting
6101, University of Colorado Hospital CRS Aurora Colorado 80045 Recruiting
31791, Whitman-Walker Institute, Inc. CRS Washington D.C. District of Columbia 20005 Not yet recruiting
5802, The Ponce de Leon Center CRS Atlanta Georgia 30308-2012 Recruiting
2701, Northwestern University CRS Chicago Illinois 60611 Not yet recruiting
2702, Rush University CRS Chicago Illinois 60612 Not yet recruiting
201, Johns Hopkins University CRS Baltimore Maryland 21205 Not yet recruiting
101, Massachusetts General Hospital CRS (MGH CRS) Boston Massachusetts 02114 Not yet recruiting
107, Brigham and Women's Hospital Therapeutics (BWH TCRS) CRS Boston Massachusetts 02115 Not yet recruiting
2101, Washington University Therapeutics (WT) CRS St Louis Missouri 63110-1010 Not yet recruiting
31786, New Jersey Medical School Clinical Research Center CRS Newark New Jersey 07103 Not yet recruiting
7804, Weill Cornell Chelsea CRS New York New York 10010 Not yet recruiting
30329, Columbia Physicians & Surgeons (P&S) CRS New York New York 10032-3732 Not yet recruiting
7803, Weill Cornell Uptown CRS New York New York 10065 Not yet recruiting
31787, University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester New York 14642 Not yet recruiting
3201, Chapel Hill CRS Chapel Hill North Carolina 27599-7215 Not yet recruiting
3203, Greensboro CRS Greensboro North Carolina 27401 Not yet recruiting
2401, Cincinnati CRS Cincinnati Ohio 45267-0405 Not yet recruiting
2501, Case CRS Cleveland Ohio 44106 Not yet recruiting
2301, Ohio State University CRS Columbus Ohio 43210-1282 Recruiting
6201, Penn Therapeutics CRS Philadelphia Pennsylvania 19104 Not yet recruiting
1001, University of Pittsburgh CRS Pittsburgh Pennsylvania 15213 Not yet recruiting
2951, The Miriam Hospital (TMH) CRS Providence Rhode Island 02904 Not yet recruiting
3652, Vanderbilt Therapeutics (VT) CRS Nashville Tennessee 37204 Not yet recruiting
31443, Trinity Health and Wellness Center CRS Dallas Texas 75208 Not yet recruiting
31473, Houston AIDS Research Team CRS Houston Texas 77030 Recruiting
1401, University of Washington Positive Research CRS Seattle Washington 98104 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05719441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05719441 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →